Daogui Yang
Papers
1
Total Citations
4
H-Index
1
About
Daogui Yang is a leading clinical researcher in gastrointestinal oncology, with a focused expertise in optimizing surgical outcomes for gastric cancer patients through perioperative interventions. His work centers on the intersection of neoadjuvant chemotherapy, minimally invasive surgery, and gut microbiome modulation. Yang’s most notable contribution is his pioneering investigation into the role of probiotic supplements in enhancing recovery after laparoscopic or robotic radical gastrectomy. As the principal investigator of the multicenter GISSG2023-01 study, he designed a rigorous randomized controlled trial protocol to evaluate how perioperative probiotics can mitigate complications and improve short-term clinical outcomes in patients who have undergone neoadjuvant chemotherapy. This work addresses a critical gap in managing advanced gastric cancer, where standard treatments often lead to significant postoperative morbidity. His protocol paper, already garnering 4 citations shortly after its 2025 publication, underscores the high interest and potential impact of his research. By bridging nutritional microbiology with advanced surgical techniques, Yang is shaping new evidence-based standards for perioperative care in gastric cancer, offering a promising pathway to improve recovery and quality of life for this challenging patient population.
Research Focus
Key Achievements
Top Papers
- 1